Test Price
2,800 AED✅ Home Collection Available
UNC119 Gene Cone-Rod Dystrophy Genetic Test in UAE – AED 2800 | DHA Licensed
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity achieved through ISO 9001:2015 accredited NGS protocols. This definitive genetic test identifies pathogenic variants in the UNC119 gene, confirming cone-rod dystrophy and enabling precise clinical management and family planning.
Premium Logistics: Experience stress‑free, hospital‑grade home collection by ISO‑certified cold‑chain specialists. Our VIP mobile phlebotomy service ensures sample integrity from your doorstep to our DHA‑licensed facility, available daily from 8 AM to 11 PM.
Clinical Guidance: Comprehensive telephonic post‑test counseling with a consultant medical genetics specialist, who interprets your results in the context of family history, retinal imaging, and electroretinography findings.
Insurance Verification: Direct billing support via WhatsApp +971 54 548 8731. Our team coordinates with all major UAE insurers to ensure a seamless claims process.
Test Overview & Methodology
The UNC119 NGS test sequences the entire coding region of the UNC119 gene, which is critical for photoreceptor function. Mutations in this gene cause autosomal dominant cone-rod dystrophy (CORD), leading to progressive loss of central and peripheral vision. Early molecular confirmation empowers patients and clinicians to access emerging therapies and plan long‑term care.
| Feature | Our Test (UNC119 NGS) | Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) | Sanger Sequencing |
| Diagnostic Precision | 99.9% sensitivity – detects all exon and intron flanking variants | Lower throughput; may miss deep intronic variants |
| Turnaround Time | 3 – 4 Weeks | 5 – 8 Weeks |
| Sample Options | Whole Blood, DNA swab, or one-drop dried blood FTA card | Whole blood only (venous draw) |
| Genetic Counseling | Pre‑ and post‑test counseling included | Often not included |
Physician Insight & Safety Protocols
"A positive UNC119 result provides a definitive molecular explanation for your retinal condition, but it must always be interpreted alongside comprehensive ophthalmologic exams and family pedigree analysis. I emphasize that this test clarifies prognosis and genetic risk, yet no single report replaces a thorough clinical evaluation by a retinal specialist."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory & Medication Guidance
Clinical Advisory Notice
Do not discontinue any prescribed vision-related medication without consulting your treating ophthalmologist. This genetic test evaluates hereditary predisposition and does not interact with or alter the effectiveness of current therapies.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not recommended for patients with recent retinal detachment surgery or active intraocular infection.
- Exclusion: Individuals unable to provide informed consent or attend genetic counseling (minors require guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Emergency Red Flags: Sudden vision loss, severe eye pain, or flashing lights with dark curtains — seek immediate emergency care.
- Minors Note: Pediatric testing must be accompanied by a genetic counseling session and written parental informed consent.
Patient FAQ & Clinical Guidance
1. What does the UNC119 cone-rod dystrophy test detect?
This NGS test comprehensively analyzes all coding exons and adjacent intronic regions of the UNC119 gene to identify disease‑causing mutations responsible for autosomal dominant cone‑rod dystrophy, delivering definitive molecular diagnosis with over 99.9% accuracy.
2. How should I prepare for the test and can I use an FTA card sample?
Preparation is minimal — maintain your usual diet and medications, but attend a genetic counseling session to document a three‑generation family pedigree. Yes, a single drop of blood on an FTA card is a convenient, validated alternative to venipuncture, especially for children or remote collections.
3. How long does it take to get results and what support is provided afterwards?
Results are available within 3 to 4 weeks. Every report includes a dedicated telephonic consultation with a consultant medical genetics specialist who explains the clinical significance, inheritance pattern, and implications for family members in plain, compassionate language.
4. Is genetic counseling included in the test price?
Yes, pre‑test and post‑test genetic counseling sessions are included in the stated price. Our genetics team guides you through the implications of your results and coordinates any necessary follow-up for at-risk family members.
5. Can this test determine if my children will inherit this condition?
Yes, once a pathogenic UNC119 variant is identified in an affected individual, cascade screening for first-degree relatives and prenatal or preimplantation genetic testing can be arranged through our genetics department.
UAE Regulatory & Data Privacy Adherence
Data Privacy Protection: This service strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic data is encrypted, securely stored, and anonymized for research only with your explicit consent.
Clinical Safety Governance: All genetic testing procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient consent, safety protocols, and clinical accountability.
DHA Licensing: Laboratory procedures comply with Dubai Healthcare City Authority (DHCA) regulations and DHA standards for genetic testing and molecular diagnostics.
Clinical & Logistical Metadata
| Test Name | UNC119 Gene Cone-Rod Dystrophy NGS Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA), Buccal Swab, or Dried Blood FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene coding region and intron-exon boundary analysis |
| ICD-10-CM Code | H35.53 (Cone-rod dystrophy), H35.5 (Hereditary retinal dystrophy), Z14.0 (Genetic carrier screening status) |
| LOINC Code | 101190-8 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians